Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

metlife inc. - MET

MET

Close Chg Chg %
77.62 0.22 0.28%

Closed Market

77.84

+0.22 (0.28%)

Volume: 2.37M

Last Updated:

May 9, 2025, 3:59 PM EDT

Trade Now

Company Overview: metlife inc. - MET

MET Key Data

Open

$78.16

 Day Range

77.69 - 78.53

52 Week Range

65.21 - 89.03

 Market Cap

$52.09B

Shares Outstanding

671.30M

 Public Float

561.49M

Beta

0.83

 Rev. Per Employee

N/A

P/E Ratio

12.63

 EPS

$6.19

Yield

280.96%

 Dividend

$0.57

EX-DIVIDEND DATE

May 6, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

3.34M

  

MET Performance

1 Week
 
 0.05%
 
1 Month
 
 9.03%
 
3 Months
 
 -4.71%
 
1 Year
 
 7.04%
 
5 Years
 
 121.04%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 91.714
Number of Ratings 20 Current Quarters Estimate 2.321
FY Report Date 06 / 2025 Current Year's Estimate 9.19
Last Quarter’s Earnings 1.96 Median PE on CY Estimate N/A
Year Ago Earnings 8.15 Next Fiscal Year Estimate 10.358
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 17 17
Mean Estimate 2.32 2.38 9.19 10.36
High Estimates 2.46 2.60 9.80 10.98
Low Estimate 2.20 2.14 8.75 9.90
Coefficient of Variance 3.23 4.58 3.41 2.93

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 12
OVERWEIGHT 2 1 1
HOLD 6 6 6
UNDERWEIGHT 0 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Apr 4, 2025 Cheryl W. Grisé Director 88,189 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 7,157,419.24
Apr 4, 2025 Mark Alan Weinberger Director 16,345 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Laura J. Hay Director 3,116 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 252,894.56
Apr 4, 2025 Diana L. McKenzie Director 21,350 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 1,732,766.00
Apr 4, 2025 Carla A. Harris Director 7,897 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 640,920.52
Apr 4, 2025 David Lawrence Herzog Director 26,138 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 2,121,360.08
Apr 4, 2025 Robert Glenn Hubbard Director 98,875 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 8,024,695.00
Apr 4, 2025 William E. Kennard Director 42,739 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 3,468,697.24
Apr 4, 2025 Jeh Charles Johnson Director 6,183 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 501,812.28
Apr 4, 2025 Edward Joseph Kelly Director 36,849 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 2,990,664.84
Apr 4, 2025 Carlos Miguel Gutierrez Director 23,289 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Denise M. Morrison Director 32,255 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 6, 2025 Michel A. Khalaf President & CEO; Director 612,483 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 52,489,793.10
Mar 6, 2025 Tamara L. Schock EVP & Chief Accounting Officer 23,606 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 2,023,034.20
Mar 6, 2025 John D. McCallion EVP & Chief Financial Officer 245,129 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 21,007,555.30
Mar 6, 2025 Monica Melchionni Curtis EVP & Chief Legal Officer 14,872 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 1,274,530.40
Mar 6, 2025 William Pappas EVP, Global Tech. & Ops. 85,746 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 7,348,432.20
Mar 6, 2025 Marlene B. Debel EVP & Chief Risk Officer 134,135 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 11,495,369.50
Mar 6, 2025 Ramy Tadros President, U.S. Business 181,368 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share 15,543,237.60
Feb 28, 2025 Michel A. Khalaf President & CEO; Director 711,550 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Metlife Inc. in the News